Search results
David R. Liu is the Richard Merkin Professor and director of the Merkin Institute of Transformative Technologies in Healthcare, vice-chair of the faculty at the Broad Institute of MIT and Harvard, the Thomas Dudley Cabot Professor of the Natural Sciences at Harvard University, and a Howard Hughes Medical Institute (HHMI) investigator.
David Ruchien Liu (born 1973) is an American molecular biologist and chemist.
David R. Liu is the Richard Merkin Professor and director of the Merkin Institute of Transformative Technologies in Healthcare, vice-chair of the faculty at the Broad Institute of MIT and Harvard, the Thomas Dudley Cabot Professor of the Natural Sciences at Harvard University, and a Howard Hughes Medical Institute (HHMI) investigator.
David R. Liu is the Richard Merkin Professor and director of the Merkin Institute of Transformative Technologies in Healthcare, vice chair of the faculty at the Broad Institute of MIT and Harvard, the Thomas Dudley Cabot Professor of the Natural Sciences at Harvard University, and a Howard Hughes Medical Institute (HHMI) investigator.
David R. Liu is the Richard Merkin Professor and director of the Merkin Institute of Transformative Technologies in Healthcare, vice-chair of the faculty at the Broad Institute of MIT and Harvard, the Thomas Dudley Cabot Professor of the Natural Sciences at Harvard University, and a Howard Hughes Medical Institute (HHMI) investigator.
David R. Liu. Harvard University. Verified email at fas.harvard.edu - Homepage. chemistry evolution genome editing DNA RNA. Title. Sort. Sort by citations Sort by year Sort by title. Cited by.
Post-doctoral applicants, admitted graduate students interested in rotating, and interested undergraduates should contact Professor David Liu directly by email (dliu@broadinstitute.org). Candidates interested in learning more about the Liu Group can email Dr. Anahita Vieira (avieira@broadinstitute.org).
During his PhD research at Berkeley, David R. Liu initiated the first general effort to expand the genetic code in living cells. As a professor at Harvard and the Broad Institute, Liu integrates chemistry and evolution to illuminate biology and develop next-generation therapeutics.
David Liu. New research: Messenger RNAs with multiple “tails” could lead to more effective therapeutics. April 3, 2024. Messenger RNA (mRNA) made its big leap into the public limelight during the pandemic, thanks to its cornerstone role in several COVID-19 vaccines.
The discovery of these bioactive molecules provide important insights into basic cellular function and are critical to identifying cellular targets implicated in human diseases. The Liu group developed and applied DNA-templated synthesis (DTS) to program chemical reactions of organic small molecules and sequence-defined synthetic polymers.
